Doyoumoney

	Dec-25	Dec-24	Dec-23	Dec-22
Operating cash flow +	-111.94	75.95	-86.83	-99.20
Net income
Depreciation, depletion and amortization	2.40	3.30	4.09	3.82
Stock-based compensation	16.40	9.65	8.75	6.74
Change in inventory
Other working capital changes	-130.74	63.01	-99.66	-109.76
Cash flow from investing +	-170.96	-1.15	-0.44	-3.17
Capital expenditures	-0.79	-1.15	-0.44	-1.97
Others incl. marketable securities changes	-170.17	0.00	0.00	-1.20
Cash flow from financing +	275.34	92.85	16.39	1.73
Dividend payout
Common stock repurchases	1.26
Net Debt Issuance	274.08	92.85	16.39	1.73

Change in cash	-7.57	167.65	-70.88	-100.65

Show Quarterly Cash Flow

	Mar-26	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	Sep-24	Jun-24	Mar-24	Dec-23	Sep-23
Operating cash flow +	-39.11	-27.73	-24.64	-30.05	-29.52	-22.45	-23.21	145.05	-23.44	-20.64	-19.97
Net income
Depreciation, depletion and amortization	0.44	0.50	0.57	0.65	0.68	0.71	0.79	0.85	0.95	0.98	1.00
Stock-based compensation	7.11	6.07	3.86	3.24	3.23	2.85	2.34	2.14	2.31	2.56	2.11
Change in inventory
Other working capital changes	-46.67	-34.30	-29.08	-33.94	-33.43	-26.01	-26.34	142.05	-26.70	-24.18	-23.09
Cash flow from investing +	6.28	-103.39	-66.88	-0.39	-0.30	-0.61	-0.10	-0.16	-0.28	-0.03	0.00
Capital expenditures	-0.09	-0.03	-0.07	-0.39	-0.30	-0.61	-0.10	-0.16	-0.28	-0.03	0.00
Others incl. marketable securities changes	6.37	-103.35	-66.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01
Cash flow from financing +	42.36	3.59	143.76	0.61	127.38	70.26	-2.15	0.15	24.58	16.19	0.01
Dividend payout
Common stock repurchases		0.64		0.61
Net Debt Issuance	42.36	2.95	143.76	0.00	127.38	70.26	-2.15	0.15	24.58	16.19	0.01

Change in cash	9.52	-127.53	52.23	-29.83	97.56	47.21	-25.46	145.04	0.87	-4.49	-19.96

Cash Flow - Maze Therapeutics, Inc. (MAZE)